Peter A. Johansson

29.8k citations
97 papers · 7.4k indexed · 1 hit paper · h-index 30

Impact in

Papers in

Peter A. Johansson

89 papers receiving 7.3k citations

Hit Papers

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes 2018 · 4.3k citations
4.3k201820262020202310002.0k3.0k4.0k

Peers

Peter A. Johansson
Comparison fields: 5 of 163
  • Endocrinology, Diabetes and Metabolism 4.4k
  • Nephrology 501
  • Cardiology and Cardiovascular Medicine 1.3k
  • Molecular Biology 3.1k
  • Surgery 1.8k
Replace Lars Melholt Rasmussen with:
Lars Melholt Rasmussen Denmark
Hironori Nakagami Japan
Yoshiji Yamada Japan
Liming Chen China
Karl T. Weber United States
Domenico Girelli Italy
Agneta Siegbahn Sweden
Robert L. Wilensky United States
Bo Zhang China
Carmen Roncal Spain
Peter A. Johansson relative to Lars Melholt Rasmussen Denmark Lars Melholt Rasmussen's profile →
Citations per field
00.5×4.7×
Lars Melholt Rasmussen · 1×
Citations per year

Countries citing papers authored by Peter A. Johansson

Since Specialization
Citations

This map shows the geographic impact of Peter A. Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Johansson more than expected).

Fields of papers citing papers by Peter A. Johansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Johansson. The network helps show where Peter A. Johansson may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter A. Johansson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter A. Johansson Line = papers co-authored together Peter A. Johansson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20240
3 20232
4 20230
5 20229
6 202124
7 202014
8 201912
9 201942
10
Novel germline variants in cutaneous and uveal melanoma families
20171
11 201631
12 2016139
13 201533
14 20156
15 2014258
16 201010
17 200944
18 200921
19 2004136
20 199719

About Peter A. Johansson

Peter A. Johansson is a scholar working on Cancer Research, Ophthalmology, Endocrinology, Diabetes and Metabolism, Oncology and Building and Construction, having authored 97 papers that have together received 7.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (16 papers), Cancer Genomics and Diagnostics (15 papers), Cutaneous Melanoma Detection and Management (13 papers), Melanoma and MAPK Pathways (11 papers), Immunotherapy and Immune Responses (9 papers), Ocular Oncology and Treatments (9 papers), Metabolism, Diabetes, and Cancer (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.4k citations), Nephrology (501 citations), Cardiology and Cardiovascular Medicine (1.3k citations), Molecular Biology (3.1k citations) and Surgery (1.8k citations). Peter A. Johansson has collaborated with scholars based in Sweden, Australia and United States. Frequent co-authors include Ingrid Gause‐Nilsson, Ofri Mosenzon, John Wilding, Lawrence A. Leiter, Deepak L. Bhatt, Darren K. McGuire, Marc S. Sabatine, Avivit Cahn, Marc P. Bonaca and Eri Kato. Their work appears in journals such as Pigment Cell & Melanoma Research, PLoS ONE, Circulation, Diabetes Obesity and Metabolism and Thermochimica Acta.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026